Management ChangeMay 29, 2026, 04:08 PM
Jazz Pharmaceuticals Director Anne O Riordan Not Seeking Re-election
AI Summary
Jazz Pharmaceuticals plc announced that Anne O Riordan, a Class III director, has informed the board that she will not seek re-election at the company's 2026 annual meeting of shareholders. Her decision was not a result of any dispute or disagreement with the company or its board. The company's board of directors will continue to assess its composition and manage board succession.
Key Highlights
- Anne O Riordan, a Class III director, will not stand for re-election at the 2026 annual meeting of shareholders.
- Ms. O Riordan's decision was not due to any dispute or disagreement with the Company or its Board.
- The Board will continue to evaluate its composition and facilitate orderly board succession processes.
Price Impact
More from JAZZ